Cerebrospinal fluid response to structured treatment interruption after virological failure.

Price, R W; Paxinos, E E; Grant, R M; Drews, B; Nilsson, A; Hoh, R; Hellmann, N S; Petropoulos, C J; Deeks, S G

Price, R W; Paxinos, E E; Grant, R M; Drews, B; Nilsson, A; Hoh, R; Hellmann, N S; Petropoulos, C J; Deeks, S G.

Affiliation

Price RW; Department of Neurology, University of California San Francisco and San Francisco General Hospital, 94110-3518, USA. price@itsa.ucsf.edu

AIDS ; 15(10): 1251-9, 2001 Jul 06.

Article in En | MEDLINE | ID: mdl-11426069

Subject(s)

Anti-HIV Agents/administration & dosage; HIV Infections/cerebrospinal fluid; HIV-1/isolation & purification; Adult; Drug Resistance, Microbial/genetics; HIV Infections/blood; HIV Infections/drug therapy; HIV Infections/virology; HIV-1/genetics; Humans; Male; Middle Aged; Mutation; Phenotype; RNA, Viral/blood; RNA, Viral/cerebrospinal fluid; Viral Load

Search on Google

Add to My VHL

XML

PubMed Links

Database: MEDLINE Main subject: HIV Infections / HIV-1 / Anti-HIV Agents Type of study: Observational_studies Limits: Adult / Humans / Male / Middle aged Language: En Journal: AIDS Journal subject: SINDROME DA IMUNODEFICIENCIA ADQUIRIDA (AIDS) Year: 2001 Type: Article Affiliation country: United States

Search on Google

Add to My VHL

XML

PubMed Links